Women's Health News

RSS

Breastfeeding while remaining on epilepsy medications may not affect child's IQ

There's good news for women with epilepsy. Breastfeeding your baby while taking your seizure medication may have no harmful effect on your child's IQ later on, according to a study published in the November 24, 2010, online issue of Neurology-, the medical journal of the American Academy of Neurology.

25 Nov 2010

Advaxis initiates ADXS11-001 clinical trial for cervix cancer

Advaxis, Inc., the live, attenuated Listeria monocytogenes (Listeria) immunotherapy company, has begun dosing patients in its 110 patient clinical trial of ADXS11-001 for the treatment of cervix cancer in women for whom cytotoxic treatment has failed.

24 Nov 2010

Heartburn drugs safe in pregnancy: Study

Pregnancy brings about a lot of heartburn sometimes beginning in the first trimester and continuing until delivery. To date the drugs available for general use in heartburn called proton-pump inhibitors or PPIs were wrought with safety concerns during pregnancy.

24 Nov 2010

A new treatment landscape for triple-negative breast cancer

A concerted R&D effort directed at triple-negative breast cancer patients promises new treatment options in the near future, according to latest research from independent market analyst, Datamonitor.

24 Nov 2010

Early urinary protein content test during pregnancy predicts later pre-eclampsia

Research led by the University of Leicester and University Hospitals of Leicester NHS Trust has provided a new advance in predicting a potentially serious pregnancy complication.

24 Nov 2010

Study reveals few advantages of prenatal diagnosis of cleft lip and palate

Many expectant parents look forward to routine ultrasounds as their first opportunity to "see" their baby. But the ultrasound can reveal that the fetus has unexpected medical conditions, such as a diagnosis of cleft lip and palate. Despite the emotional distress the diagnosis can bring, it can also offer the opportunity to prepare for the child's future needs. However, a study has found little difference between mothers who were given a prenatal diagnosis of cleft lip and palate and those who discovered the problem at birth.

24 Nov 2010

Blocking miR-375 microRNA in ERalha-positive breast cancer cells slows down cancer cell growth

Two thirds of breast cancers are ERalpha-positive, i.e., many estrogen receptors of the ERalpha- type are found in their cells. "These molecules can interact with the estrogen hormone and, thus, even lead to cancer," explains Dr. Joerg Hoheisel; molecular biologist at DKFZ. "The connection between the levels of the estrogen receptor alpha and the occurrence of breast cancer has been known for some time now.

24 Nov 2010

The effects of pregnancy on oral health

Even though most people are aware that good oral health is essential for the overall health of both mother and child, misunderstandings about the safety of dental care during pregnancy may cause pregnant women to avoid seeing their dentist. The fact is that dentists can create a treatment plan that is safe, effective, and essential for combating the adverse effects of oral disease during pregnancy.

24 Nov 2010

IDSI submits Premarket Notification for CTLM breast imaging device to FDA

Imaging Diagnostic Systems, Inc., a pioneer in laser breast imaging, announced today that a Premarket Notification 510(k) was submitted on Monday, November 22, 2010, to the United States Food and Drug Administration (FDA). With this submission, the company moves forward in the process of seeking marketing clearance for its innovative breast imaging device, the CTLM system.

23 Nov 2010

Women view their weight wrong: Study

Researchers have found that among more than 2,200 women ages 18 to 25 seen at several Texas reproductive-health clinics there were many who did not know if they weighed normal or were overweight.

23 Nov 2010

Hologic announces receipt of FDA approvable letter for Selenia Dimensions 3-D digital mammography system

Hologic, Inc., a leading developer, manufacturer and supplier of premium diagnostics products, medical imaging systems and surgical products dedicated to serving the healthcare needs of women, announced today that Hologic has received an approvable letter from the U.S. Food and Drug Administration (FDA) for the Selenia Dimensions three-dimensional (3-D) digital mammography tomosynthesis system.

From Hologic, Inc. 23 Nov 2010

Scientists establish new biological links between early puberty and obesity

An international group of scientists, including researchers at the Medical Research Council (MRC), has discovered 30 genes that control the age at which girls reach sexual maturity. They found that many of the genes responsible for puberty also play a strong role in how the body metabolises fat, establishing new biological links between going through puberty at a young age and being at increased risk of obesity.

23 Nov 2010

Study substantiates targeted breast ultrasound as primary technique to evaluate focal breast signs, symptoms

Targeted breast ultrasound should be the primary imaging technique used to evaluate focal (confined) breast signs and symptoms in women younger than 30, according to a study in the December issue of the American Journal of Roentgenology (www.ajronline.org).

23 Nov 2010

High BMI remains primary problem among wealthier women in developing countries

A new study from the Harvard School of Public Health (HSPH) finds that high body mass index (BMI) in developing countries remains primarily a problem of the rich. The findings suggest that the shift towards overweight and obesity among the poor that has already happened in wealthier countries has not yet happened in developing countries.

23 Nov 2010

Late-preterm babies at increased risk for cognitive, emotional problems

Late-preterm babies - those born between 34 and 36 weeks - are at an increased risk for cognitive and emotional problems, regardless of maternal IQ or demographics, according to new research published by Michigan State University researchers in the current edition of the journal Pediatrics.

23 Nov 2010

Neurocrine announces results from elagolix Phase II Daisy PETAL study in endometriosis

Neurocrine Biosciences, Inc. today announced results from the open-label portion of the six month Phase II Daisy PETAL study (901 study) using its proprietary, orally-active nonpeptide Gonadotropin-Releasing Hormone (GnRH) receptor antagonist, elagolix, in patients with endometriosis.

22 Nov 2010

Research shows association between childhood CKD and maternal diabetes, obesity

Children with Chronic Kidney Disease (CKD) are more likely to have mothers who were obese or had diabetes during pregnancy, according to a study presented at the American Society of Nephrology's 43rd Annual Meeting and Scientific Exposition, by Christine W. Hsu, MD (University of Washington, Seattle) and colleagues.

22 Nov 2010